COCP

insider transactions

Cocrystal Pharma, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 365d

+120.0K

120.0K buy · 0 sell

Net value · 365d

$114.5K

$114.5K in · $0 out

Sentiment · 365d

Net buying

100% buying · 0% selling

Open-market trades · 365d

120.0K buy · 0 sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 3, 26

James Sapirstein KEY

Chief Executive Officer

$0

235.0K sh

Own New
Buy·P
Feb 24, 26

Phillip Frost MD ET AL

Director, 10% Owner

$20.0K

20.0K sh · $1.00

Own +1%
Buy·P
Feb 6, 26

Phillip Frost MD ET AL

Director, 10% Owner

$47.3K

50.0K sh · $0.95

Own +3%
Grant·A
Jan 9, 26

Roger D. Kornberg

Director

$0

24.6K sh

Own New
Grant·A
Jan 9, 26

Richard C Pfenniger JR

Director

$0

16.4K sh

Own New
Grant·A
Jan 9, 26

Sam Lee KEY

President and Co-CEO

$0

49.2K sh

Own New
Grant·A
Jan 9, 26

Fred Hassan

Director

$0

16.4K sh

Own New
Grant·A
Jan 9, 26

James Joseph Martin KEY

Co-CEO and CFO

$0

49.2K sh

Own New
Grant·A
Jan 9, 26

Phillip Frost MD ET AL

Director, 10% Owner

$0

24.6K sh

Own New
Grant·A
Jan 9, 26

Anthony J Japour

Director

$0

16.4K sh

Own New
Grant·A
Jan 9, 26

Steven D Rubin

Director

$0

16.4K sh

Own New
Buy·P
Dec 31, 25

Phillip Frost MD ET AL

Director, 10% Owner

$47.3K

50.0K sh · $0.95

Own +3%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 3, 2026	James Sapirstein KEY	Chief Executive Officer	Grant A	235.0K	New	—	$0
Feb 24, 2026	Phillip Frost MD ET AL	Director, 10% Owner	Buy P	20.0K	+1%	$1.00	$20.0K
Feb 6, 2026	Phillip Frost MD ET AL	Director, 10% Owner	Buy P	50.0K	+3%	$0.95	$47.3K
Jan 9, 2026	Roger D. Kornberg	Director	Grant A	24.6K	New	—	$0
Jan 9, 2026	Richard C Pfenniger JR	Director	Grant A	16.4K	New	—	$0
Jan 9, 2026	Sam Lee KEY	President and Co-CEO	Grant A	49.2K	New	—	$0
Jan 9, 2026	Fred Hassan	Director	Grant A	16.4K	New	—	$0
Jan 9, 2026	James Joseph Martin KEY	Co-CEO and CFO	Grant A	49.2K	New	—	$0
Jan 9, 2026	Phillip Frost MD ET AL	Director, 10% Owner	Grant A	24.6K	New	—	$0
Jan 9, 2026	Anthony J Japour	Director	Grant A	16.4K	New	—	$0
Jan 9, 2026	Steven D Rubin	Director	Grant A	16.4K	New	—	$0
Dec 31, 2025	Phillip Frost MD ET AL	Director, 10% Owner	Buy P	50.0K	+3%	$0.95	$47.3K

About COCP insider trading

This page tracks insider transactions for Cocrystal Pharma, Inc. (COCP) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.